Literature DB >> 8289072

Clinical signs of brain death simulated by Guillain-Barré syndrome.

J F Martí-Massó1, J Suárez, A López de Munain, N Carrera.   

Abstract

A 58-year-old woman with relapsing acute Guillain-Barré syndrome separated by long asymptomatic intervals presented clinical symptoms resembling those of brain death. She remained in this situation for 15 days and recovered with amnesia for this period. The amnesia was not explained either by metabolic encephalopathy or by sedative drugs. This case stresses the importance of the precise etiologic diagnosis of severe brain disease and the isoelectric EEG in brain death.

Entities:  

Mesh:

Year:  1993        PMID: 8289072     DOI: 10.1016/0022-510x(93)90034-v

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

Review 1.  Fulminant acute inflammatory demyelinating polyradiculoneuropathy: case report and literature review.

Authors:  Michael Moussouttas; Dipak Chandy; Frances Dyro
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Fulminant inflammatory neuropathy mimicking cerebral death.

Authors:  Maarika Liik; Leena Puksa; Siiri-Merike Lüüs; Sulev Haldre; Pille Taba
Journal:  BMJ Case Rep       Date:  2012-07-20

Review 3.  Difference in central and peripheral recovery in a patient with severe axonal motor neuropathy and central nervous system involvement and review of literature.

Authors:  Shade' B Moody; Ruchi J Wanchoo; Giridhar P Kalamangalam; Ernesto Infante; Kazim A Sheikh
Journal:  J Clin Neuromuscul Dis       Date:  2013-03

4.  Long-term impact after fulminant Guillain-Barré syndrome, case report and literature review.

Authors:  Alain Rougé; Jérémie Lemarié; Sébastien Gibot; Pierre Edouard Bollaert
Journal:  Int Med Case Rep J       Date:  2016-11-07

5.  A Case of Acute Motor Axonal Neuropathy Mimicking Brain Death and Review of the Literature.

Authors:  Sandhya Ravikumar; Poysophon Poysophon; Roy Poblete; May Kim-Tenser
Journal:  Front Neurol       Date:  2016-04-26       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.